Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00613886
Other study ID # HS 2005-4609
Secondary ID J&J Proposal #38
Status Terminated
Phase N/A
First received
Last updated
Start date March 2006
Est. completion date April 2009

Study information

Verified date December 2020
Source University of California, Irvine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The research project is designed to determine which combination of tests will enable physicians to predict whether a patient with symptoms of normal pressure hydrocephalus (NPH) will improve with a shunt.


Description:

Normal pressure hydrocephalus (NPH) is a potentially reversible progressive neurological condition disproportionately affecting the elderly population. Given current controversies regarding its exact definition, accurate incidence and prevalence figures are elusive. NPH was first described forty years ago as a triad of symptoms consisting of gait difficulties, urinary incontinence, and memory problems in patients with enlarged ventricles in the absence of increased intracranial pressure (ICP). The cause of primary, or idiopathic NPH (INPH) remains elusive, while secondary NPH results from intracranial insults such as head trauma, meningitis, or intracranial hemorrhage. NPH can be successfully treated with cerebrospinal fluid (CSF) shunting. However, the accurate diagnosis and treatment of patients with NPH remains problematic, despite significant advances in brain imaging and ICP physiology. Objectives - The primary aims of this study are: 1. to confirm the ability of external lumbar drainage to increase the success rate of selectively shunting patients with NPH compared to historical controls 2. to refine the diagnosis of NPH by determining whether the factors that change before and after lumbar drainage will predict failure to improve after shunting. A related aim is to assess the complications attributable to lumbar drainage. 3. to perform a preliminary evaluation of programmable shunt valves for NPH compared to historical controls using fixed-pressure valves. A related aim is to determine whether post-op objective analysis of gait, cognitive function and urinary symptoms will help refine the programmable shunt setting on an individual basis. Secondary study aims include: Investigating the pathophysiology of NPH by: 1) correlating cortical vein compliance measured by MRI flow quantification studies with CSF pressure waveform analysis; 2)assessing funduscopic changes before and during ELD; 3) performing and cross correlating CSF chemical analysis on screening positive and negative patients as well as screening-positive patients who are shunt responsive versus unresponsive.


Recruitment information / eligibility

Status Terminated
Enrollment 24
Est. completion date April 2009
Est. primary completion date April 2009
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Walking difficulties in both legs which has developed gradually, not explained by other conditions, either in combination with mental impairment and urinary incontinence - Brain CT or MRI findings of enlarged ventricles compared to established standards (minimum Evans ratio of 0.30 as measured by reviewing films) - Mental impairment must be mild to moderate, emerging with or after the walking difficulties - Age > or = 18 years old - MMSE (Mini-mental status exam): < or = 10 - Urinary incontinence Exclusion Criteria: - No or only minimal walking difficulties combined with severe dementia - Severe medical problems with limited life expectancy (less than six months) - Contraindications to surgery - Lack of informed consent

Study Design


Intervention

Device:
Programmable Shunt Insertion (Codman, Medtronic)
Medical Device - Shunt insertion surgery of adjustable valve and laparoscopic assistance for placement of peritoneal catheter. Patient will be brought to operating room suite where general anesthesia is induced. Patient will be placed with a small roll on shoulder, supine, on the operating room table. Patient's head will be turned with the parietal area uppermost in the field. Patient will be prepared and draped in the usual sterile fashion. Site prep includes parietooccipital area, side of neck, chest, and entire abdomen. Ventricular catheter placed and then attached to shunt valve. Catheter is then fitted over grooved blue burr hole guide. Excess catheter pulled down to pull valve into pocket on the skull. Sterile dressings applied.
Behavioral:
Assessments in physical therapy, occupational therapy, and speech therapy
Follow-up testing to be administered by trained Physician Assistant in the outpatient setting on an approximately monthly basis: 10m walk, timed up-and-go, Mini-Mental Status Exam, 9-hole Grooved Pegboard, Motor Visual Perception Test (MVPT), Modified Rankin Score (MRS)

Locations

Country Name City State
United States University of California, Irvine - Medical Center Orange California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evans Ratio A brain CT scan is obtained after the first week to ten days and the shunt is adjusted according to the patients signs and symptoms. Prior to any downward adjustment of the shunt valve (which allows more CSF drainage), a brain CT is obtained to look for subdural hematoma or effusion. If any type of subdural collection is found, the valve pressure is increased (to reduce CSF flow) until the collection resolves. initial and follow-up visits
Secondary Physical Therapy, Occupational Therapy, and Speech Therapy The evaluations for physical therapy, occupational therapy and speech therapy are performed along with external lumbar drainage (ELD) to assess NPH subjects. 30 min per clinic visit
See also
  Status Clinical Trial Phase
Terminated NCT00149721 - Anterior Pituitary Function in Patients With Hydrocephalus N/A
Completed NCT00196196 - A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System. Phase 3
Not yet recruiting NCT05562596 - Normal Pressure Hydrocephalus Biomarkers Investigation
Unknown status NCT00874198 - European Study on Prediction of Outcome in Patients With Idiopathic Normal Pressure Hydrocephalus N/A
Completed NCT00233701 - Normal Pressure Hydrocephalus (NPH) Registry Phase 4
Withdrawn NCT00793416 - ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients Phase 4
Recruiting NCT05910944 - European Study of Prodromal iNPH
Active, not recruiting NCT01909960 - Flow MRI in Normal Pressure Hydrocephalus N/A
Completed NCT02016352 - Cerebrospinal Fluid Proteome in Hydrocephalus N/A
Terminated NCT01092546 - Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus Phase 3
Completed NCT01815775 - Predictive Value of Flow MRI in Normal Pressure Hydrocephalus Surgery Phase 0
Recruiting NCT03877107 - Effect of Depletive Lumbar Puncture on Lower Urinary Tract Dysfunction in iNPH N/A
Enrolling by invitation NCT03269201 - Brain Network Activation in Patients With Movement Disorders
Recruiting NCT03245138 - Endoscopic Third Ventriculostomy Versus Ventriculo-peritoneal Shunting in Idiopathic Normal Pressure Hydrocephalus N/A
Terminated NCT00727142 - Conservative Versus Surgical Management of Idiopathic Normal Pressure Hydrocephalus (INPH) N/A
Recruiting NCT04471740 - Normal Pressure Hydrocephalus and Sleep Apnea N/A
Completed NCT01798641 - A Randomized Cross-over Study for Normal Pressure Hydrocephalus N/A
Recruiting NCT01618500 - Computerised Testing of Cognitive Response to Cerebrospinal Fluid Shunting in Idiopathic Normal Pressure Hydrocephalus N/A
Completed NCT00600795 - Prognostic Value of Transforming Growth Factor-Beta 1 in Normal Pressure Hydrocephalus N/A
Terminated NCT03521518 - CPT-3 in Normal Pressure Hydrocephalus